Mario Bertazzoli is a physician and a registered specialist in Human Reproduction Pathology. He received both medical and specialization degrees from the University of Milan, Italy and worked as physician at the Obstetric and Gynaecological Department, University of Milan, and for the Italian National Health Service, district of Milan.
Since 1995 he worked for international pharmaceutical companies as pharmacovigilance and pharmaco-epidemiology physician. In the year 2001 he was appointed Head of Corporate Drug Safety and EU qualified Person for PharmacoVigilance and from the year 2009 Director, Group Head of Drug Safety and Reference Physician to the EU Qualified Person for PharmacoVigilance for the Helsinn Group (Helsinn Healthcare SA, Lugano- Switzerland, Helsinn Birex Pharmaceutical Ltd Dublin-Ireland and Helsinn Therapeutics US, Iselin, New Jersey-USA.
He is Founder and Treasurer of the International Society of Pharmacovigilance, Swiss-Austrian Chapter, lecturer at University of Milan and author of more than 50 scientific publications or international/national congresses or symposia presentations.